Roadshow
NK Cell Therapy Culture Medium (DSNK)
Introduction of Products
1. NK Cell Therapy Culture Medium (DSNK)
Developed by Professor Shi Zibi
Used in cell therapy (GMP grade)
Simple operation process and high efficacy
Obtained TFDA medical device certification
Collaborating partners applied for special management regulations from the Ministry of Health and Welfare
2. CTC Enrichment Kit
Invented by CellSearch inventor (Professor Leon Terstappen) who published two papers using our EpCAM antibodies
Completed clinical trials with four major teaching hospitals in Taiwan (head and neck cancer, gastric cancer, breast cancer, colorectal cancer, non-small cell lung cancer)
CTC Automation Instrument
Commissioned GMP factory production
Can process blood from 12 patients simultaneously
3. MSC Cell Therapy Culture Medium
Used for mesenchymal stem cell (MSC) culture
Can also be used for exosome production
Huge potential market
Simple operation process and high efficacy
Raw materials are from the United States, meeting FDA standards includes basal medium and supplements
Introduction of Products
1. NK Cell Therapy Culture Medium (DSNK)
Developed by Professor Shi Zibi
Used in cell therapy (GMP grade)
Simple operation process and high efficacy
Obtained TFDA medical device certification
Collaborating partners applied for special management regulations from the Ministry of Health and Welfare
Advantages:
High NK cell proliferation rate >1500 times
High NK purity >90%
Strong cytotoxic effect of cell line >80%
Direct use, no need for pre-embedding antibodies
PBMC direct culture, no need for NK purification beforehand
2. CTC Enrichment Kit
Invented by CellSearch inventor (Professor Leon Terstappen) who published two papers using our EpCAM antibodies
Completed clinical trials with four major teaching hospitals in Taiwan (head and neck cancer, gastric cancer, breast cancer, colorectal cancer, non-small cell lung cancer)
CTC Automation Instrument
Commissioned GMP factory production
Can process blood from 12 patients simultaneously
3. MSC Cell Therapy Culture Medium
Used for mesenchymal stem cell (MSC) culture
Can also be used for exosome production
Huge potential market
Simple operation process and high efficacy
Raw materials are from the United States, meeting FDA standards includes basal medium and supplements
- Established 2023
- Company BioMab, Inc.
- Telephone +886-2-27188451
- Email joshua.ho@biomabinc.com
- Address Room 308, Building B, No.18, SiYuan St., Zhongzheng Dist., Taipei City,10091, Taiwan
Company overview
BioMab Inc. focuses on immune-technology based products and aims to be the largest medium and reagent supplier in the cell therapy industry in Taiwan. The company was spun off from Academia Sinica in Taiwan and has strong R&D capabilities. BioMab's circulating tumor cell (CTC) detection platform is sourced from Academia Sinica, and BioMab has obtained exclusive worldwide authorization from Academia Sinica. Current product lines include the CTC detection platform and NK cell & MSC cell culture platforms, providing a one-stop technology platform, from cancer screening to treatment and post-recovery tracking. The company's products have been recognized by many domestic and international customers. BioMab Inc. also works with many prestigious research institutions domestically and internationally for development and research.